1. Home
  2. CLSD vs PSQH Comparison

CLSD vs PSQH Comparison

Compare CLSD & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • PSQH
  • Stock Information
  • Founded
  • CLSD 2011
  • PSQH 2021
  • Country
  • CLSD United States
  • PSQH United States
  • Employees
  • CLSD N/A
  • PSQH N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • PSQH Advertising
  • Sector
  • CLSD Health Care
  • PSQH Consumer Discretionary
  • Exchange
  • CLSD Nasdaq
  • PSQH Nasdaq
  • Market Cap
  • CLSD 68.6M
  • PSQH 81.5M
  • IPO Year
  • CLSD 2016
  • PSQH N/A
  • Fundamental
  • Price
  • CLSD $0.92
  • PSQH $2.02
  • Analyst Decision
  • CLSD Strong Buy
  • PSQH Strong Buy
  • Analyst Count
  • CLSD 5
  • PSQH 2
  • Target Price
  • CLSD $5.20
  • PSQH $6.00
  • AVG Volume (30 Days)
  • CLSD 103.8K
  • PSQH 758.2K
  • Earning Date
  • CLSD 05-14-2025
  • PSQH 05-08-2025
  • Dividend Yield
  • CLSD N/A
  • PSQH N/A
  • EPS Growth
  • CLSD N/A
  • PSQH N/A
  • EPS
  • CLSD N/A
  • PSQH N/A
  • Revenue
  • CLSD $1,664,000.00
  • PSQH $26,483,166.00
  • Revenue This Year
  • CLSD N/A
  • PSQH $85.69
  • Revenue Next Year
  • CLSD $675.15
  • PSQH $62.08
  • P/E Ratio
  • CLSD N/A
  • PSQH N/A
  • Revenue Growth
  • CLSD N/A
  • PSQH 201.84
  • 52 Week Low
  • CLSD $0.70
  • PSQH $1.63
  • 52 Week High
  • CLSD $1.65
  • PSQH $7.77
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 62.45
  • PSQH 52.60
  • Support Level
  • CLSD $0.81
  • PSQH $1.71
  • Resistance Level
  • CLSD $0.90
  • PSQH $2.23
  • Average True Range (ATR)
  • CLSD 0.05
  • PSQH 0.17
  • MACD
  • CLSD 0.01
  • PSQH 0.06
  • Stochastic Oscillator
  • CLSD 99.85
  • PSQH 60.68

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

Share on Social Networks: